HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Sijie Li Selected Research
Sijie Li Research Topics
Disease
21
Ischemic Stroke
04/2024 - 01/2015
19
Breast Neoplasms (Breast Cancer)
03/2024 - 04/2012
18
Stroke (Strokes)
04/2024 - 07/2013
18
Neoplasms (Cancer)
02/2024 - 04/2014
9
Infarction (Infarctions)
03/2024 - 11/2013
5
Brain Ischemia (Cerebral Ischemia)
01/2024 - 07/2013
4
Cognitive Dysfunction
05/2024 - 08/2021
4
Ischemia
01/2023 - 10/2017
4
Hypoxia (Hypoxemia)
01/2023 - 08/2018
3
Cerebral Infarction
04/2024 - 11/2013
3
Cerebral Hemorrhage
04/2024 - 01/2020
3
Neoplasm Metastasis (Metastasis)
02/2024 - 01/2022
3
Reperfusion Injury
01/2023 - 05/2013
3
Triple Negative Breast Neoplasms
01/2022 - 01/2020
2
Inflammation (Inflammations)
01/2024 - 04/2022
2
Moyamoya Disease (Moya-Moya Disease)
11/2023 - 10/2017
2
Pathologic Constriction (Stenosis)
11/2023 - 12/2022
2
Brain Injuries (Brain Injury)
11/2023 - 10/2018
2
Hypertension (High Blood Pressure)
10/2023 - 01/2023
2
Weight Gain
10/2023 - 05/2020
2
Communicable Diseases (Infectious Diseases)
12/2020 - 01/2020
2
Infections
12/2020 - 04/2014
2
Tuberous Sclerosis (Bourneville's Disease)
01/2020 - 10/2019
2
Carcinogenesis
01/2019 - 12/2018
2
Shock
08/2015 - 01/2014
1
Neurocognitive Disorders (Clerambault Syndrome)
05/2024
1
Hemorrhage
04/2024
1
Hypersensitivity (Allergy)
03/2024
1
Squamous Cell Carcinoma of Head and Neck
02/2024
1
Vascular Remodeling
02/2024
1
Lung Neoplasms (Lung Cancer)
11/2023
1
Cataract (Cataracts)
11/2023
1
Macular Degeneration (Age-Related Maculopathy)
11/2023
1
Neutropenia
10/2023
1
Primary Headache Disorders
10/2023
1
Anemia
10/2023
1
No-Reflow Phenomenon
10/2023
1
Fatigue
10/2023
1
Vision Disorders (Hemeralopia)
10/2023
1
Exanthema (Rash)
10/2023
1
Edema (Dropsy)
10/2023
1
Diarrhea
10/2023
1
Constipation
10/2023
Drug/Important Bio-Agent (IBA)
9
Biomarkers (Surrogate Marker)
IBA
04/2024 - 10/2017
9
Long Noncoding RNA
IBA
01/2023 - 01/2019
8
Proteins (Proteins, Gene)
FDA Link
02/2024 - 07/2013
5
Neuroprotective Agents
IBA
11/2023 - 11/2015
4
Tamoxifen
FDA Link
Generic
03/2024 - 04/2014
4
RNA (Ribonucleic Acid)
IBA
03/2024 - 01/2019
4
Estrogen Receptors
IBA
05/2023 - 10/2018
3
Tirofiban (Aggrastat)
FDA Link
04/2024 - 08/2021
3
Therapeutic Uses
IBA
02/2024 - 01/2015
3
Paclitaxel (Taxol)
FDA Link
Generic
05/2023 - 10/2018
3
Circular RNA
IBA
05/2023 - 01/2021
3
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
09/2022 - 11/2013
2
Glucose (Dextrose)
FDA Link
Generic
03/2024 - 08/2021
2
Ligands
IBA
02/2024 - 01/2018
2
Coloring Agents (Dyes)
IBA
01/2024 - 10/2019
2
Iron
IBA
11/2023 - 10/2019
2
Estrogen Receptor alpha
IBA
01/2023 - 12/2018
2
Oxygen (Dioxygen)
IBA
01/2023 - 08/2018
2
salicylhydroxamic acid (SHAM)
IBA
12/2022 - 10/2017
2
Streptococcus pneumoniae plY protein
IBA
01/2022 - 09/2020
2
Competitive Endogenous RNA
IBA
01/2022 - 01/2020
2
Messenger RNA (mRNA)
IBA
10/2019 - 07/2013
2
hydroxide ion
IBA
08/2015 - 01/2014
2
Protein Kinase C
IBA
11/2013 - 01/2011
1
Interleukin-33
IBA
05/2024
1
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
04/2024
1
Dihydrotachysterol (AT 10)
IBA
04/2024
1
Sulfasalazine (Azulfidine)
FDA Link
Generic
03/2024
1
CXC Chemokines
IBA
02/2024
1
Cysteine (L-Cysteine)
FDA Link
02/2024
1
Hematoxylin (Haematoxylon)
IBA
01/2024
1
Eosine Yellowish-(YS) (Eosin)
IBA
01/2024
1
peoniflorin
IBA
01/2024
1
Insulin-Like Growth Factor II (Somatomedin A)
IBA
01/2024
1
atractylenolide I
IBA
01/2024
1
atractylenolide III
IBA
01/2024
1
Aspartate Aminotransferases (Aspartate Transaminase)
IBA
10/2023
1
Lipids
IBA
10/2023
1
ceritinib
IBA
10/2023
1
Alanine Transaminase (SGPT)
IBA
10/2023
1
ensartinib
IBA
10/2023
1
alectinib
IBA
10/2023
1
Tyrosine Kinase Inhibitors
IBA
10/2023
1
brigatinib
IBA
10/2023
1
Creatinine
IBA
10/2023
1
Anaplastic Lymphoma Kinase
IBA
10/2023
1
Crizotinib
IBA
10/2023
Therapy/Procedure
17
Therapeutics
04/2024 - 10/2017
13
Thrombectomy
02/2024 - 07/2018
4
Immunotherapy
02/2024 - 12/2020
4
Drug Therapy (Chemotherapy)
01/2023 - 12/2018
2
Adjuvant Chemotherapy
01/2023 - 10/2018
2
Ischemic Postconditioning
01/2023 - 05/2013
2
Neoadjuvant Therapy
08/2022 - 01/2021
2
Immunomodulation
09/2020 - 01/2020
2
Lasers (Laser)
08/2015 - 01/2014
1
Anesthesia
05/2024